| Literature DB >> 24395458 |
Bilal Abou Ali1, Ralph Nader, Hani Tamim, Toufic Eid, Fouad Boulos, Nabil Khoury, Samir Akel, Rachid Haidar, Said Saghieh, Miguel Abboud, Samar Muwakkit, Hassan El-Solh, Raya Saab.
Abstract
Treatment of Ewing sarcoma (ES) necessitates coordinated multi-disciplinary care. We analyzed outcome for 39 patients treated at a single institution in Lebanon, a developing country with available multidisciplinary treatment modalities, where financial barriers to care are overcome by a fundraising system. Median follow-up was 58 months. Five-year overall and event-free survival were 76% and 58%, respectively, for localized disease, and 40% and 38%, respectively, for metastatic disease. We conclude that, in a country with emerging economy, by following international protocols and ensuring availability of needed resources, outcome of patients with ES is similar to that in developed countries.Entities:
Keywords: Ewing sarcoma; pediatric; prognostic factors
Mesh:
Year: 2014 PMID: 24395458 DOI: 10.1002/pbc.24926
Source DB: PubMed Journal: Pediatr Blood Cancer ISSN: 1545-5009 Impact factor: 3.167